rs141926826
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001017980.4(VMA21):āc.182A>Gā(p.Asn61Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000368 in 1,208,466 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 102 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ). Synonymous variant affecting the same amino acid position (i.e. N61N) has been classified as Likely benign.
Frequency
Consequence
NM_001017980.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VMA21 | NM_001017980.4 | c.182A>G | p.Asn61Ser | missense_variant | 3/3 | ENST00000330374.7 | |
VMA21 | NM_001363810.1 | c.347A>G | p.Asn116Ser | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.182A>G | p.Asn61Ser | missense_variant | 3/3 | 1 | NM_001017980.4 | P1 | |
VMA21 | ENST00000370361.5 | c.347A>G | p.Asn116Ser | missense_variant | 4/4 | 5 | |||
VMA21 | ENST00000477649.1 | n.262A>G | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00188 AC: 208AN: 110477Hom.: 0 Cov.: 22 AF XY: 0.00147 AC XY: 48AN XY: 32675
GnomAD3 exomes AF: 0.000535 AC: 98AN: 183159Hom.: 0 AF XY: 0.000370 AC XY: 25AN XY: 67599
GnomAD4 exome AF: 0.000216 AC: 237AN: 1097937Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 54AN XY: 363311
GnomAD4 genome AF: 0.00188 AC: 208AN: 110529Hom.: 0 Cov.: 22 AF XY: 0.00147 AC XY: 48AN XY: 32737
ClinVar
Submissions by phenotype
VMA21-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 16, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
X-linked myopathy with excessive autophagy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at